Patent · US Expired

Angiogenesis--inhibiting protein binding peptides and proteins and methods of use

US6201104A · kind A · utility

60Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 1998
Grant dateMar 13, 2001
Priority date
Expiry dateDec 4, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to peptides and proteins such as receptors that bind angiogenesis-related proteins ANGIOSTATIN.TM. protein or ENDOSTATIN.TM. protein. Peptides and proteins of the present invention can be isolated from body fluids including blood or urine, or can be synthesized by recombinant, enzymatic or chemical methods. The peptides are particularly important for identifying receptors of angiogenesis-related proteins, as well as for identifying other proteins that regulate, transport and otherwise interact with angiogenesis-related proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.